Neo-Advent Technologies, LLC is an innovative technology development enterprise that has been incorporated in 2003. The founding group of Company's principals possesses decades of combined experience in the fields of polymer science, advanced materials, drug discovery and development, and pharmaceutical formulations.  In many areas NAT quickly grew up from a consulting services’ model to an integrated profitable business with a strong internal experimental base and an extended line of clients.

NAT currently provides an extensive set of services to the industrial, academic, and government entities. The Company takes a pride in delivering high quality and high impact results to its clients and partners in the most cost- and time-effective manner while building the relations that last and flourish.

OUR TEAM

Nelson Landrau, President and CEO

Mr. Nelson Landrau co-founded Neo-Advent Technologies, LLC. He is an entrepreneur with a variety of hands-on technical skills and over 20 years of experience in polymer and synthetic organic chemistry, materials sciences, and drug formulation.  Early in his professional career Mr. Landrau established a track record in the design of advanced coatings and polymeric materials while working for Foster Miller and Eikos. His efforts resulted in multiple patents and two NASA awards in late 1990s for novel thermoset plasticizers for polyimide resins and high temperature micron-sized polymer spheres. Later on he successfully applied his superb knowledge of the polymer systems in the pharmaceutical setting at Inotek Pharmaceuticals where he spearheaded design and operation of the synthetic scale-up lab and then ventured in drug formulation arena. Mr. Landrau holds a M.S. degree in Chemistry from the University of Massachusetts.

Tian Hao, Ph.D., Director of Drug Formulations

Dr. Hao is a formulator extraordinaire that combines vast experience in many fundamental areas of polymer and colloidal chemistry and hands-on skills in pharmaceutical formulation of both of liquid and solid dosage forms. His professional experience has been recognized by participation in the review panels of the National Science Foundation as well as European and Israel Science Foundations. He has extensively published in the field including a recent book “Granular Materials: Physical Properties and Pharmaceutical Applications”, CRC/Taylor Francis, 2010. Dr. Hao received his Ph.D. degree in Polymer Sciences and Colloidal Chemistry from the Institute of Chemistry, Chinese Academy of Sciences, and carried out a postdoctoral research at the Toho University and the National Institute of Material and Chemistry Research (Tsukuba) in Japan, and at the Rutgers University. He subsequently worked at the E Ink and Vertex Pharmaceuticals, Cambridge, MA.

Pierre Leblanc, Ph.D., Head of Biology

Dr. Leblanc is a biochemist with 20 years of academic and industrial experience in cellular and molecular immunology and biotechnology.  His work has focused on studies of regulation and de-regulation of the immune response. He served as a Director of Research at Oncogene Products and contributed to the development of novel antibody products and assay designs. He then joined Eikos, Inc. as Director of Molecular Biology and successfully managed several SBIR Phase I&II projects related to the US Army-sponsored antimalarial drug development.  He lately carried out research at Shriners Hospital and Massachusetts General Hospital. Dr. Leblanc holds a Ph.D. degree in Biochemistry from McMaster University in Canada. His postdoctoral research is from the Boston University and MIT, Boston, MA.

Yosif Golfman, Ph.D., Principle Scientist, Material Sciences

Dr. Golfman is an engineer with more than 30 years of experience in polymer science and composite materials development and testing for military and civilian applications. He is an expert in the design of high performance plastics and related strain/stress analysis and has extensively worked on improvement of wearing properties, adhesive strength and durability of fiberglass, graphite/epoxy, carbon/carbon, and other composites. Dr. Golfman received a Ph.D. in Mechanical Engineering from the Shipbuilding Institute in Saint-Petersburg, Russia and after relocation to US worked for Adtech Systems Research, Wright Patterson Air Force Base, (Dayton, OH), Spectran Inc. (Sturbridge, MA), and Foster Miller (Waltham, MA).

ADVISORS

Alex Nivorozhkin, Ph.D.

Dr. Nivorozhkin is an entrepreneur and a team builder in life sciences’ arena with vast experience and track record in an early technology transfer and development. He is a co-founding member of Boston BioCom, LLC, a biopharma company funded by the seed investment from Pfizer. Alex gained substantial experience in the commercial aspects of drug discovery and development at Epix Medical and Inotek Pharmaceuticals where he served as the company’s Head of Medicinal Chemistry. He served as a Senior Program Manager at the Center of Integration of Medicine and Innovative Technologies (CIMIT) at MGH, a consortium of the Harvard Medical School-affiliated hospitals, Boston University, Draper Laboratory and MIT aimed at developing new medical devices; and a Scientific Programs Officer at Sheldon and Miriam Adelson Medical Research Foundation. He is a co-inventor of several drug candidates that have advanced to clinical trials and late pre-clinical studies in the United States, has co-authored over 60 scientific publications in different areas of chemistry, chemical biology, and material sciences and holds 12 patents. Alex received a Ph.D. in Physical Organic Chemistry from Rostov University and carried out postdoctoral research at the University Paris-Sud, France, and the Department of Chemistry and Chemical Biology, Harvard University, Cambridge.

Oleg Evgenov, M.D., Ph.D.

Dr. Evgenov is a renowned expert in oxidative stress and critical care, and pulmonary medicine. He has published extensively on the nitric oxide pathways, pulmonary hypertension, sepsis, related small and big animal models, and drug development strategies. He is an attending physician at the Department of Anesthesia, Critical Care and Pain Medicine at the Mass General Hospital, Boston, MA. Dr. Evgenov graduated from the Medical University in Arkhangelsk, Russia and received a Ph.D. degree (pulmonary and cardiovascular physiology) from the University of Tromso in Norway. He completed a residency in Anesthesiology at Harvard Medical School/MGH. He has received a number of prestigious international awards and prizes from the International Sepsis Forum, Nitric Oxide Society, the Scandinavian Society of Anesthesiology. Oleg serves as a regular peer-reviewer and a member of editorial boards for more than 20 leading medical journals. He is an elected member of the American Society of Anesthesiologists, the Thoracic Society, and the American Physiological Society.